| Literature DB >> 25281301 |
Zhi-Ping Liu, Hulin Wu, Jian Zhu1, Hongyu Miao.
Abstract
BACKGROUND: Respiratory epithelial cells are the primary target of influenza virus infection in human. However, the molecular mechanisms of airway epithelial cell responses to viral infection are not fully understood. Revealing genome-wide transcriptional and post-transcriptional regulatory relationships can further advance our understanding of this problem, which motivates the development of novel and more efficient computational methods to simultaneously infer the transcriptional and post-transcriptional regulatory networks.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25281301 PMCID: PMC4287445 DOI: 10.1186/1471-2105-15-336
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Figure 1Illustration of the performance evaluation of SITPR using an example regulatory network. (A) The background regulatory network with 10 nodes. 'G3’ denotes a miRNA and is labeled in magenta. (B) The activated regulatory relationships (edges in color). The numbers next to the edges are the regulatory strengths. (C) An example of the inferred activated regulatory network using SITPR. (D) The ROC curve and the six performance evaluations at the maximum F-measure point.
Performance evaluation and comparison of SITPR, PCC, MI, CLR, ARACNE, GENIE3 and TIGRESS for networks of three different sizes
| Method | Node Size | SN | SP | ACC | F-measure | MCC | AUC |
|---|---|---|---|---|---|---|---|
| SITPR | 10 | 0.886 ± 0.090 | 0.971 ± 0.069 | 0.943 ± 0.667 | 0.925 ± 0.070 | 0.875 ± 0.144 | 0.966 ± 0.069 |
| 50 | 0.775 ± 0.089 | 0.635 ± 0.088 | 0.670 ± 0.054 | 0.690 ± 0.039 | 0.358 ± 0.062 | 0.703 ± 0.037 | |
| 100 | 0.690 ± 0.080 | 0.478 ± 0.101 | 0.530 ± 0.079 | 0.557 ± 0.080 | 0.147 ± 0.110 | 0.573 ± 0.071 | |
| PCC | 10 | 0.400 ± 0.241 | 0.486 ± 0.125 | 0.457 ± 0.133 | 0.398 ± 0.204 | -0.112 ± 0.293 | 0.596 ± 0.082 |
| 50 | 0.495 ± 0.157 | 0.453 ± 0.167 | 0.463 ± 0.124 | 0.444 ± 0.105 | -0.043 ± 0.189 | 0.557 ± 0.038 | |
| 100 | 0.534 ± 0.084 | 0.526 ± 0.057 | 0.528 ± 0.045 | 0.525 ± 0.050 | 0.052 ± 0.045 | 0.517 ± 0.027 | |
| MI | 10 | 0.243 ± 0.243 | 0.679 ± 0.097 | 0.533 ± 0.092 | 0.293 ± 0.256 | -0.101 ± 0.255 | 0.567 ± 0.062 |
| 50 | 0.590 ± 0.145 | 0.527 ± 0.106 | 0.543 ± 0.065 | 0.542 ± 0.036 | 0.103 ± 0.072 | 0.574 ± 0.027 | |
| 100 | 0.539 ± 0.063 | 0.569 ± 0.079 | 0.561 ± 0.050 | 0.547 ± 0.030 | 0.095 ± 0.052 | 0.568 ± 0.024 | |
| CLR | 10 | 0.400 ± 0.148 | 0.543 ± 0.096 | 0.495 ± 0.068 | 0.441 ± 0.081 | -0.055 ± 0.143 | 0.540 ± 0.059 |
| 50 | 0.565 ± 0.133 | 0.510 ± 0.090 | 0.523 ± 0.061 | 0.520 ± 0.072 | 0.064 ± 0.107 | 0.539 ± 0.066 | |
| 100 | 0.568 ± 0.130 | 0.543 ± 0.102 | 0.549 ± 0.059 | 0.538 ± 0.044 | 0.098 ± 0.084 | 0.550 ± 0.039 | |
| ARACNE | 10 | 0.500 ± 0.168 | 0.643 ± 0.181 | 0.595 ± 0.117 | 0.532 ± 0.105 | 0.151 ± 0.213 | 0.577 ± 0.084 |
| 50 | 0.620 ± 0.118 | 0.508 ± 0.119 | 0.535 ± 0.067 | 0.539 ± 0.0275 | 0.114 ± 0.062 | 0.547 ± 0.043 | |
| 100 | 0.576 ± 0.112 | 0.525 ± 0.108 | 0.537 ± 0.062 | 0.531 ± 0.039 | 0.089 ± 0.062 | 0.554 ± 0.050 | |
| GENIE3 | 10 | 0.429 ± 0.252 | 0.521 ± 0.147 | 0.490 ± 0.163 | 0.443 ± 0.21 | -0.050 ± 0.345 | 0.609 ± 0.057 |
| 50 | 0.565 ± 0.116 | 0.444 ± 0.228 | 0.473 ± 0.157 | 0.444 ± 0.162 | -0.007 ± 0.187 | 0.529 ± 0.041 | |
| 100 | 0.512 ± 0.093 | 0.544 ± 0.062 | 0.536 ± 0.043 | 0.520 ± 0.050 | 0.049 ± 0.077 | 0.521 ± 0.033 | |
| TIGRESS | 10 | 0.629 ± 0.168 | 0.586 ± 0.171 | 0.600 ± 0.127 | 0.583 ± 0.135 | 0.205 ± 0.233 | 0.586 ± 0.122 |
| 50 | 0.490 ± 0.152 | 0.463 ± 0.105 | 0.470 ± 0.09 | 0.461 ± 0.095 | -0.041 ± 0.167 | 0.536 ± 0.067 | |
| 100 | 0.554 ± 0.127 | 0.507 ± 0.083 | 0.519 ± 0.058 | 0.515 ± 0.070 | 0.053 ± 0.105 | 0.549 ± 0.033 |
For fairness of comparison when evaluating the performances, all the methods are assigned the same task (that is, identify the activated regulatory relationships for a given background network).
Effects of the noise level and the total number of background edges on the performance of SITPR based on 100 simulation runs
| Noise | SN | SP | ACC | F-measure | MCC | AUC |
|---|---|---|---|---|---|---|
| 10% | 0.913 ± 0.086 | 0.994 ± 0.044 | 0.967 ± 0.057 | 0.950 ± 0.057 | 0.928 ± 0.093 | 0.986 ± 0.045 |
| 20% | 0.867 ± 0.143 | 0.933 ± 0.141 | 0.911 ± 0.126 | 0.893 ± 0.131 | 0.816 ± 0.253 | 0.924 ± 0.133 |
| 30% | 0.889 ± 0.182 | 0.886 ± 0.174 | 0.887 ± 0.155 | 0.876 ± 0.171 | 0.775 ± 0.304 | 0.889 ± 0.158 |
| Background edge number | SN | SP | ACC | F-measure | MCC | AUC |
| 40 | 0.884 ± 0.067 | 0.920 ± 0.071 | 0.897 ± 0.059 | 0.900 ± 0.059 | 0.787 ± 0.120 | 0.940 ± 0.060 |
| 80 | 0.854 ± 0.108 | 0.854 ± 0.104 | 0.854 ± 0.103 | 0.852 ± 0.100 | 0.629 ± 0.192 | 0.893 ± 0.095 |
| 100 | 0.829 ± 0.112 | 0.770 ± 0.093 | 0.820 ± 0.095 | 0.792 ± 0.083 | 0.521 ± 0.152 | 0.811 ± 0.071 |
Ten co-regulation motifs and their occurrence frequencies in the background network and the activated network
| Motif ID | Network | Occurrence | Z-Score |
|---|---|---|---|
| M1 | Background | 1541 | 24.114 |
| Active | 16 | 153.470 | |
| M2 | Background | 21317 | 8.412 |
| Active | 209 | 2.356 | |
| M3 | Background | 45171 | -3.933 |
| Active | 109 | -54.482 | |
| M4 | Background | 27987 | 3.685 |
| Active | 153 | 1.053 | |
| M5 | Background | 187341 | -1.152 |
| Active | 1647 | -20.769 | |
| M6 | Background | 2931 | -1.091 |
| Active | - | - | |
| M7 | Background | 20060 | 1.017 |
| Active | 59 | 0.914 | |
| M8 | Background | 3226 | -0.624 |
| Active | 13 | 25.591 | |
| M9 | Background | 481293 | -0.478 |
| Active | 38 | 0.626 | |
| M10 | Background | 88102 | -0.230 |
| Active | 273 | -24.802 |
Motifs are ordered according to their absolute Z-scores in the background regulatory network, which are calculated using FANMOD [50]. Motifs 'M1’, 'M2’, and 'M3’ are statistically significant in both the background and the activated regulatory networks (threshold of 2). 'M5’, 'M8’ and 'M10’ are not statistically significant in the background regulatory network, while they become significant in the activated regulatory network.
Figure 2Expression patterns of selected TFs (A), miRNAs (B) and target genes (C) in the combined co-regulation motifs (D). The first motif cluster in (D) contains the motifs 'CEBPB’-'hsa-miR-191’-'CCL5’/'TRIM28’/'ISG20’/'ABCG1’ etc., and the second motif cluster contains 'BRCA1’-'hsa-miR-28-5p’-'TUBB’/'POLR2A’.
Functional terms of GO biological processes and KEGG/REACTOME pathways enriched in 25 selected regulatory modules (FDR < 0.05)
| Module | Term | Representative genes |
| FDR |
|---|---|---|---|---|
| Module103 | GO:0008283 ~ cell proliferation | CREBBP | 0.000353 | 0.00498 |
| GO:0006357 ~ regulation of transcription from RNA polymerase II promoter | CREBBP, EP300 | 0.003488 | 0.04824 | |
| Module106 | GO:0019221 ~ cytokine-mediated signaling pathway | IRAK4 | 0.001318 | 0.0192 |
| hsa04630:Jak-STAT signaling pathway | IFNAR1, STAT2, IRF9 | 0.002251 | 0.0177 | |
| Module130 | GO:0006915 ~ apoptosis | HSPE1 | 0.001585 | 0.01762 |
| Module159 | GO:0007249 ~ I-kappaB kinase/NF-kappaB cascade | IRF3, TRAF2, TICAM1, BCL3 | 3.58E-08 | 5.43E-07 |
| GO:0043068 ~ positive regulation of programmed cell death | TRAF2, TICAM1, BCL3 | 1.46E-07 | 2.21E-06 | |
| GO:0002263 ~ cell activation during immune response | TICAM1, BCL3 | 2.23E-05 | 0.00034 | |
| GO:0002366 ~ leukocyte activation during immune response | TICAM1, BCL3 | 2.23E-05 | 0.00034 | |
| hsa04622:RIG-I-like receptor signaling pathway | IRF3, TRAF2, MAVS | 2.27E-05 | 0.00021 | |
| GO:0001819 ~ positive regulation of cytokine production | TRAF2, MAVS, TICAM1, BCL3 | 0.000347 | 0.00526 | |
| GO:0051251 ~ positive regulation of lymphocyte activation | TRAF2, TICAM1 | 0.000433 | 0.00655 | |
| GO:0045321 ~ leukocyte activation | TICAM1, BCL3 | 0.00047 | 0.00711 | |
| GO:0006955 ~ immune response | MAVS, TICAM1, BCL3 | 0.000483 | 0.00731 | |
| GO:0009615 ~ response to virus | IRF3, MAVS, TICAM1, BCL3 | 0.000609 | 0.0092 | |
| REACT_6900:Signaling in Immune system | IRF3, TICAM1 | 0.001402 | 0.00804 | |
| Module171 | hsa04310:Wnt signaling pathway | JUN, MAPK10, DVL2 | 0.000233 | 0.00246 |
| hsa04010:MAPK signaling pathway | JUN, MAPK10, MAPK1 | 0.001514 | 0.01594 | |
| GO:0034097 ~ response to cytokine stimulus | JUN | 0.00196 | 0.03023 | |
| GO:0002237 ~ response to molecule of bacterial origin | JUN, MAPK1 | 0.002673 | 0.04102 | |
| Module173 | GO:0006954 ~ inflammatory response | CEBPB, CCL5, F8, BDKRB1, ITGB2, HIF1A, TF, F3, C1RL, IL8 | 3.00E-05 | 0.00048 |
| GO:0009611 ~ response to wounding | CEBPB, CCL5, F8, BDKRB1, IGFBP1, ITGB2, NRG1, HIF1A, TF, F3, C1RL, IL8 | 5.28E-05 | 0.00085 | |
| GO:0051240 ~ positive regulation of multicellular organismal process | CCL5, PTGS2, NRG1, HIF1A, MYLK2, TF, F3, IL27RA | 0.000197 | 0.00316 | |
| GO:0006952 ~ defense response | CEBPB, CCL5, F8, BDKRB1, ITGB2, HIF1A, TF, F3, IL27RA, C1RL, IL8 | 0.000835 | 0.01331 | |
| GO:0032101 ~ regulation of response to external stimulus | CCL5, VEGFA, PTGS2, NT5E, F3, IL8 | 0.001131 | 0.01799 | |
| REACT_604:Hemostasis | STX4, SLC7A7, F8, VEGFA, ITGB2, ALB, TF, F3 | 0.001131 | 0.00976 | |
| GO:0002526 ~ acute inflammatory response | CEBPB, F8, TF, F3, C1RL | 0.0014 | 0.02222 | |
| GO:0043069 ~ negative regulation of programmed cell death | CEBPB, VEGFA, NRG1, ALB, KRT18, PPT1, PCSK6, F3 | 0.001937 | 0.03062 | |
| Module174 | GO:0051726 ~ regulation of cell cycle | SMAD3, CDK4 | 1.10E-05 | 0.00016 |
| GO:0031328 ~ positive regulation of cellular biosynthetic process | SMAD3, CDK4 | 0.000612 | 0.00894 | |
| GO:0006350 ~ transcription | SMAD3, ASH2L | 0.000854 | 0.01245 | |
| Module175 | GO:0000122 ~ negative regulation of transcription from RNA polymerase II promoter | CTNNB1, | 0.002252 | 0.02972 |
| Module178 | GO:0051252 ~ regulation of RNA metabolic process | STAT1, UBE2I, HDAC3, PIAS2, DAXX, SP100 | 5.05E-05 | 0.00076 |
| REACT_11061:Signalling by NGF | HDAC3, AKT1 | 0.000413 | 0.00293 | |
| GO:0007049 ~ cell cycle | DAXX, UBE2I, HDAC3, AKT1 | 0.0005 | 0.00753 | |
| hsa04630:Jak-STAT signaling pathway | STAT1, AKT1, PIAS2 | 0.004991 | 0.04684 | |
| Module179 | GO:0006974 ~ response to DNA damage stimulus | RAD54L, FANCI, XAB2, BCCIP, BRCA1, XRCC1, EEPD1, UPF1, RAD51, TOP2A, FANCD2, RAD54B | 3.39E-08 | 4.91E-07 |
| REACT_216:DNA Repair | FANCI, XAB2, BRCA1, XRCC1, POLR2K, RAD51, POLR2A, FANCD2 | 1.64E-07 | 1.25E-06 | |
| GO:0033554 ~ cellular response to stress | FANCI, RAD54L, XAB2, EEPD1, BRCA1, XRCC1, TOP2A, RAD54B, DHX9, BCCIP, UPF1, RAD51, FANCD2 | 2.71E-07 | 3.92E-06 | |
| GO:0007049 ~ cell cycle | FANCI, RAD54L, KIF15, BRCA1, CHTF18, RCC1, RAD54B, CIT, BCCIP, UPF1, TUBB, RAD51, FANCD2 | 7.43E-06 | 0.00011 | |
| Module180 | GO:0010604 ~ positive regulation of macromolecule metabolic process | NUP62 | 7.41E-05 | 0.0011 |
| Module182 | GO:0006303 ~ double-strand break repair via nonhomologous end joining | PRKDC | 1.88E-06 | 2.83E-05 |
| GO:0045935 ~ positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | ILF2, RELA, NFKB1, PRKDC | 0.000934 | 0.01395 | |
| GO:0002562 ~ somatic diversification of immune receptors via germline recombination within a single locus | PRKDC | 0.001732 | 0.02573 | |
| Module184 | GO:0022402 ~ cell cycle process | MLH1, MAP2K6 | 0.001302 | 0.01777 |
| Module185 | GO:0007243 ~ protein kinase cascade | SRC, IKBKB, NFKBIA | 0.001885 | 0.02759 |
| Module186 | REACT_1538:Cell Cycle Checkpoints | MCM4, MCM3, MCM5, MCM7, MCM2 | 9.90E-23 | 7.84E-22 |
| GO:0006260 ~ DNA replication | MCM4, MCM3, MCM5, MCM7, MCM2 | 1.13E-21 | 1.51E-20 | |
| Module189 | GO:0032268 ~ regulation of cellular protein metabolic process | CBS | 0.00036 | 0.00532 |
| Module190 | GO:0008380 ~ RNA splicing | SFPQ | 2.23E-06 | 3.19E-05 |
| Module200 | REACT_6185:HIV Infection | NUP188, NUP205 | 0.000592 | 0.00484 |
| Module206 | hsa04350:TGF-beta signaling pathway | SMURF2, SMAD6 | 0.001698 | 0.00872 |
| Module241 | GO:0006913 ~ nucleocytoplasmic transport | NXT1, RAN | 0.001111 | 0.01645 |
| Module244 | REACT_12472:Regulatory RNA pathways | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 5.52E-10 | 3.65E-09 |
| REACT_6143:Pausing and recovery of Tat-mediated HIV-1 elongation | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 4.94E-09 | 3.27E-08 | |
| REACT_6167:Influenza Infection | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 4.39E-06 | 2.91E-05 | |
| Module253 | GO:0000398 ~ nuclear mRNA splicing, via spliceosome | HNRNPM | 0.003042 | 0.04485 |
| Module267 | hsa04920:Adipocytokine signaling pathway | RXRB | 8.48E-06 | 7.22E-05 |
| Module280 | GO:0006984 ~ ER-nuclear signaling pathway | PAK1, EIF2AK3 | 0.001649 | 0.02486 |
| Module303 | hsa04144:Endocytosis | VPS28 | 0.000182 | 0.00041 |
'Module’ refers to the module indices we gave. 'Term’ refers to the enriched GO terms (e.g. GO:0008283), KEGG pathways (e.g. hsa04630), and REACTOME pathways (e.g. REACT_6900). Certain genes in the modules are listed as 'Representative genes’. 'p-value’ and 'FDR’ shows the statistical significance of the results.
Figure 3The activated regulatory relationships in two example modules. TFs, miRNAs and genes are in cyan, magenta and green, respectively. The up-regulation and down-regulation are labeled in red and blue, respectively. The background regulatory relationships which are not activated are in gray. The 'arrow’, 'T’ and 'diamond’ shapes of edge terminals denote to up-, down-, and undetermined- regulations, respectively. (A) Module173. This module contains the co-regulation motifs 'CEBPB’-'hsa-miR-191’-'CCL5’ and 'CEBPB’-'hsa-miR-191’-'ALB’/'ISG20’. It also contains some two-node regulatory motifs, e.g., 'ETS2’-'ETS2’, 'NFKB2’-'hsa-miR-1227’, 'IRF5’-'CCL5’ and 'hsa-miR-191’-'REPS1’. (B) Module179. This module contains the regulatory motifs 'BRCA1’-'has-miR-28-5p’-'TUBB’/'POLR2A’, “EGR1’-'hsa-miR-155*’, 'EGR1’-'hsa-miR-146a’-'LTB’ and 'BRCA1’-'hsa-miR-146a’-'PHF1’.
Figure 4The activated regulatory network in the KEGG IAV gene set. The genes in the IAV pathway together with their neighbors from the background network were analyzed. The importance of miRNAs can be told from the co-regulation motifs, such as 'STAT2’-'hsa-miR-583’-'IRF9’, 'ATF2’-'hsa-miR-374b’-'JAK1’, 'IKBKB’-'hsa-miR-218’-'AKT1’, and 'MAPK1’-'hsa-miR-543’-'IL8’.
Figure 5Illustration of regulatory relationships and the dynamic Bayesian network (DBN) model. (A) Five types of regulatory relationships among TF, miRNA and target gene. (B) Example of a DBN model for a 3-node network.